亨廷顿病的基因组特征 基因修饰剂告知药物向可处理性
Kevin Lucy Namuli1,2, Alana N Slike1,2, Mason A Hollebeke1,2
1Department of Pharmacology and Therapeutics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, CanadaR3E 0T6.
Brain communications
|January 13, 2025
概括
这项研究确定了修复亨廷顿病发作的关键DNA修复基因,揭示了重复扩张障碍的共同机制,并将PMS1作为有前途的药物标优先考虑. 人类遗传数据指导亨廷顿病的治疗开发.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 亨廷顿病 (HD) 是由HTT基因的CAG重复扩张引起的,但临床变异性超过了重复长度预测.
- 全基因组关联研究 (GWAS) 表明DNA修复基因会影响HD的发病,但因果基因和治疗潜力仍未得到充分探索.
研究的目的:
- 通过大规模的遗传数据,识别和优先考虑亨廷顿病的强大候选修饰基因.
- 评估重复扩张障碍的共享遗传结构,并评估已识别的修饰基因的药物可用性.
主要方法:
- 来自一项大型疾病发病年龄研究 (n=9064) 和X关联的 dystonia-parkinsonism 的 GWAS 数据的分析.
- 候选修改基因的生物信息优先级,补充了人类遗传存储库和外体研究.
- 对基因药用性进行评估,包括人类遗传约束,蛋白相互作用和RNA表达特异性.
主要成果:
- 观察到高相关性 (R2=0.78) 在GWAS中击中HD和X链接的 dystonia-parkinsonism之间的高相关性,表明共享的修饰机制.
- 与癌症相关的MLH1,PMS2和MSH3等DNA修复基因可能会构成药物标限制.
- 根据人类遗传证据和药物可用性评估,PMS1成为最有前途的药物标候选人.
结论:
- 人类基因组数据对于优先考虑亨廷顿病修饰基因作为可行的药物标至关重要.
- 探索修饰基因为直接针对亨廷顿病的HTT提供了一个替代的治疗策略.
- 这些发现为开发针对亨廷顿病和其他重复扩张障碍的治疗方法提供了基础.
更多相关视频
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
2.4K
11:22Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Published on: June 27, 2018
7.9K
相关概念视频
Human Genetics
529
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
529
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
Genetic Lingo
100.7K
Overview
100.7K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
